Definitive Healthcare Corp.
NASDAQ:DHMedical - Healthcare Information Services
+$0.01 today
- Market cap
- $143.60M
- Beta
- 1.33
- P/E (TTM)
- -0.5
- EPS (TTM)
- -$1.63
Volume 0.43M
Average 0.32M
DH Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Definitive Healthcare Corp.NASDAQ: DH
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization declines year over year
Q1 FY2026 depreciation & amortization of $13.25M fell 4.1% year over year, in line with the -3.7% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 43.8% from the prior quarter. Over 3 fiscal years it compounded at -14.3% a year.
Context
- Depreciation & amortization amounted to 14.8% of revenue in FY2025, down 5.7 pp from a year earlier.
- Depreciation & amortization increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -4.1% toward the trailing-twelve-month pace of -3.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 35.82M USD
- Year-over-year change
- -30.7%
- 4-year CAGR
- -12.1%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 35.82M | -30.7% |
| FY2024 | 2024-12-31 | 51.67M | -0.2% |
| FY2023 | 2023-12-31 | 51.75M | -9.1% |
| FY2022 | 2022-12-31 | 56.9M | -5.1% |
| FY2021 | 2021-12-31 | 59.95M | — |
Depreciation & Amortization vs competitors
How DH compares with its peers on the latest reported figures
- DH's LTM Mar 2026 depreciation & amortization of $50.86M is the highest of the 10 companies compared; the peer median is $4.42M.
- Its year-over-year change of -3.7% is the 5th highest of 10, against a peer median of -8.2%.
- Depreciation & amortization amounts to 21.3% of revenue for DH, versus a peer median of 8.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $50.86M | -3.7% | -14.3% | 21.3% | |
| LTM Mar 2026 | $26.73M | -8.2% | +4.0% | 7.7% | |
| LTM Mar 2026 | $8.65M | -2.0% | +19.6% | 10.7% | |
| LTM Mar 2026 | $8.25M | +34.9% | +13.0% | 6.0% | |
| LTM Feb 2026 | $6.57M | -18.0% | +32.0% | 8.2% | |
| LTM Mar 2026 | $4.42M | +12.1% | -1.3% | 3.2% | |
| LTM Mar 2026 | $3.84M | -39.2% | -5.9% | 9.9% | |
| LTM Mar 2026 | $1.93M | +926.2% | +25.6% | 49.3% | |
| LTM Mar 2026 | $1.65M | -13.9% | +19.6% | — | |
| LTM Mar 2026 | $1.5M | -16.9% | +11.8% | — | |
| Peer median (excluding DH) | $4.42M | -8.2% | +13.0% | 8.2% | |
Competitors are the stored peer set for DH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 166.15M | 222.65M | 251.42M | 252.2M | 241.52M |
| Cost of Revenue | 40.69M | 42.63M | 47.48M | 54.73M | 58.25M |
| Gross Profit | 125.47M | 180.03M | 203.93M | 197.47M | 183.28M |
| Gross Margin | 75.5% | 80.9% | 81.1% | 78.3% | 75.9% |
| Research & Development | 18.57M | 34.89M | 42.44M | 36.52M | 34.78M |
| Selling, General & Admin | 89.25M | 141.15M | 153.4M | 133.07M | 133.26M |
| Operating Expenses | 152.78M | 224.07M | 533.73M | 908.29M | 203.86M |
| Depreciation & Amortization | 59.95M | 56.9M | 51.75M | 51.67M | 35.82M |
| EBITDA | 23.08M | 26.23M | (241.23M) | (567.24M) | (162.15M) |
| EBITDA Margin | 13.9% | 11.8% | -95.9% | -224.9% | -67.1% |
| Operating Income | (27.32M) | (44.04M) | (329.8M) | (710.82M) | (20.58M) |
| Operating Margin | -16.4% | -19.8% | -131.2% | -281.8% | -8.5% |
| Interest Income | 29K | 2.79M | 13.64M | 14.59M | 6.95M |
| Interest Expense | 25.9M | 11.2M | 15.2M | 14.84M | 11.29M |
| Other Income / Expenses | (35.45M) | 2.17M | 21.62M | 77.08M | (188.67M) |
| Income Before Tax | (62.77M) | (41.88M) | (308.18M) | (633.75M) | (209.26M) |
| Pre-Tax Margin | -37.8% | -18.8% | -122.6% | -251.3% | -86.6% |
| Income Tax Expense | (443K) | (17.7M) | (18.55M) | (42.3M) | (9.96M) |
| Net Income | (51.91M) | (7.22M) | (202.39M) | (413.12M) | (138.93M) |
| Net Margin | -31.2% | -3.2% | -80.5% | -163.8% | -57.5% |
| EPS (Basic) | (0.19) | (0.07) | (1.79) | (3.54) | (1.30) |
| EPS (Diluted) | (0.19) | (0.07) | (1.79) | (3.54) | (1.30) |
| Weighted Avg Shares | 97.03M | 101.11M | 112.76M | 116.64M | 106.65M |
| Weighted Avg Shares (Diluted) | 97.03M | 101.11M | 112.76M | 116.64M | 106.65M |
Definitive Healthcare Corp.
NASDAQ:DH
Intrinsic Alpha fair value
Locked
Current Price
$1.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.